Prise en charge diagnostique et thérapeutique de la migraine chez l’adulte et chez l’enfant

[1]  Priya Sharma.  The impact of sugar , 2017 .

[2]  S. Sacco,et al.  Migraine in pregnancy , 2015, The Journal of Headache and Pain.

[3]  E. Loder,et al.  The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines , 2012, Headache.

[4]  S. Silberstein,et al.  Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults , 2012, Neurology.

[5]  W. Becker,et al.  Canadian Headache Society guideline for migraine prophylaxis. , 2012, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques.

[6]  E. Loder,et al.  Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators , 2012, Cephalalgia : an international journal of headache.

[7]  R. Shukla,et al.  Guidelines on the diagnosis and the current management of headache and related disorders , 2011, Annals of Indian Academy of Neurology.

[8]  Seemant Chaturvedi,et al.  Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[9]  R. Lipton,et al.  Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study , 2010, Cephalalgia : an international journal of headache.

[10]  R. B. Machado,et al.  Epidemiological and clinical aspects of migraine in users of combined oral contraceptives. , 2010, Contraception.

[11]  Kay Dickersin,et al.  Outcome reporting in industry-sponsored trials of gabapentin for off-label use. , 2009, The New England journal of medicine.

[12]  O. Spigset,et al.  Maternal Characteristics and Migraine Pharmacotherapy During Pregnancy: Cross-Sectional Analysis of Data from a Large Cohort Study , 2009, Cephalalgia : an international journal of headache.

[13]  B. Kaneshiro,et al.  An evidence-based approach to hormonal contraception and headaches. , 2009, Contraception.

[14]  M. Kallela,et al.  Short-Term Frovatriptan for the Prevention of Difficult-To-Treat Menstrual Migraine Attacks , 2009, Cephalalgia : an international journal of headache.

[15]  R. Lipton,et al.  Migraine and cardiovascular disease: systematic review and meta-analysis , 2009, BMJ : British Medical Journal.

[16]  A. May,et al.  EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force , 2009, European journal of neurology.

[17]  H. Diener,et al.  Telmisartan in Migraine Prophylaxis: A Randomized, Placebo-Controlled Trial , 2009, Cephalalgia : an international journal of headache.

[18]  V. Tripathi,et al.  Contraception for women: an evidence based overview , 2009, BMJ : British Medical Journal.

[19]  C. Bushnell,et al.  Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study , 2009, BMJ : British Medical Journal.

[20]  J. Hulihan,et al.  Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs. , 2009, Clinical therapeutics.

[21]  K. Keskinbora,et al.  A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine , 2008, Clinical Neurology and Neurosurgery.

[22]  S. Silberstein,et al.  Diagnosis and Treatment of the Menstrual Migraine Patient , 2008, Headache.

[23]  V. Shaygannejad,et al.  A double‐blind, randomized trial of low‐dose topiramate vs propranolol in migraine prophylaxis , 2008, Acta neurologica Scandinavica.

[24]  D. Dodick,et al.  Acute treatment and prevention of menstrually related migraine headache , 2008, Neurology.

[25]  P J Goadsby,et al.  Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan , 2008, Cephalalgia : an international journal of headache.

[26]  M. Rupnow,et al.  Effect of Early Intervention With Almotriptan vs Placebo on Migraine‐Associated Functional Disability: Results From the AEGIS Trial , 2008, Headache.

[27]  G. Gilbert.  MIGRAINE IN ADOLESCENTS: ASSOCIATION WITH SOCIOECONOMIC STATUS AND FAMILY HISTORY , 2008, Neurology.

[28]  R. Kessler,et al.  Impact of comorbidity on headache-related disability , 2008, Neurology.

[29]  B. Trujillo-Hernández,et al.  Subcutaneous Histamine versus Topiramate in Migraine Prophylaxis: A Double-Blind Study , 2008, European Neurology.

[30]  R. Millán-Guerrero,et al.  Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double‐blind study , 2007, European journal of neurology.

[31]  S. Kittner,et al.  Probable Migraine With Visual Aura and Risk of Ischemic Stroke: The Stroke Prevention in Young Women Study , 2007, Stroke.

[32]  T. Kurth.  Migraine with aura and ischemic stroke: which additional factors matter? , 2007, Stroke.

[33]  L. Pinessi,et al.  Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study , 2007, International journal of clinical practice.

[34]  E. MacGregor,et al.  Migraine and use of combined hormonal contraceptives: a clinical review , 2007, Journal of Family Planning and Reproductive Health Care.

[35]  N. Kıylıoğlu,et al.  Epidemiology and Clinical Characteristics of Migraine Among School Children In The Menderes Region , 2007, Cephalalgia : an international journal of headache.

[36]  E. Loder,et al.  Rizatriptan for the Acute Treatment of ICHD-II Proposed Menstrual Migraine: Two Prospective, Randomized, Placebo-Controlled, Double-Blind Studies , 2007, Cephalalgia : an international journal of headache.

[37]  R. Schellenberg,et al.  Nebivolol and Metoprolol for Treating Migraine: An Advance on β‐Blocker Treatment? , 2007, Headache.

[38]  F. O’Donnell,et al.  Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. , 2007, JAMA.

[39]  E. MacGregor,et al.  Migraine in pregnancy and lactation: a clinical review , 2007, Journal of Family Planning and Reproductive Health Care.

[40]  J. Hulihan,et al.  Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT® 12.5 mg Time Versus Intensity Migraine Study (AIMS) , 2007, Headache.

[41]  A. May,et al.  Headache Prevalence Among Adolescents — The German DMKG Headache Study , 2007, Cephalalgia : an international journal of headache.

[42]  R. Lipton,et al.  Probable Migraine in the United States: Results Of The American Migraine Prevalence and Prevention (AMPP) Study , 2007, Cephalalgia : an international journal of headache.

[43]  R. Lipton,et al.  Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.

[44]  K. Hagen,et al.  Hormone replacement therapy and headache prevalence in postmenopausal women. The Head‐HUNT study , 2007, European journal of neurology.

[45]  J. Tajti,et al.  Diclofenac Epolamine is Effective in The Treatment of Acute Migraine Attacks. A Randomized, Crossover, Double Blind, Placebo-Controlled, Clinical Study , 2007, Cephalalgia : an international journal of headache.

[46]  E. MacGregor,et al.  Menstrual migraine: a clinical review , 2007, Journal of Family Planning and Reproductive Health Care.

[47]  A. Hackshaw,et al.  Prevention of menstrual attacks of migraine , 2006, Neurology.

[48]  E. Loder,et al.  Patterns of Diagnosis and Acute and Preventive Treatment for Migraine in the United States: Results from the American Migraine Prevalence and Prevention Study , 2006, Headache.

[49]  G. Shukla,et al.  Low‐Dose Topiramate Versus Lamotrigine in Migraine Prophylaxis (The Lotolamp Study) , 2006, Headache.

[50]  S. Silberstein,et al.  Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study. , 2006, Clinical therapeutics.

[51]  L. Metsähonkala,et al.  Long-term Trends in the Incidence of Headache in Finnish Schoolchildren , 2006, Pediatrics.

[52]  R. Cady,et al.  Efficacy of Rizatriptan 10 mg Administered Early in a Migraine Attack , 2006, Headache.

[53]  V. Shaygannejad,et al.  Comparison of the Effect of Topiramate and Sodium Valporate in Migraine Prevention: A Randomized Blinded Crossover Study , 2006, Headache.

[54]  S. Akgöz,et al.  Headache Prevalence in Adolescents Aged 12 to 17: A Student‐Based Epidemiological Study in Bursa , 2006, Headache.

[55]  M. Behbehani,et al.  Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis—Part 2 , 2006, Headache.

[56]  K. Hagen,et al.  Oral contraceptives and increased headache prevalence , 2006, Neurology.

[57]  W. Pryse-Phillips,et al.  Pain Free Efficacy of Sumatriptan in the Early Treatment of Migraine , 2006, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[58]  M. Behbehani,et al.  Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis—Part I , 2006, Headache.

[59]  S. Silberstein,et al.  Tramadol/Acetaminophen for the Treatment of Acute Migraine Pain: Findings of a Randomized, Placebo‐Controlled Trial , 2005, Headache.

[60]  L. C. Santos,et al.  Critical Analysis of the International Classification of Headache Disorders Diagnostic Criteria (ICHD I-1988) and (ICHD II-2004), for Migraine in Children and Adolescents , 2005, Cephalalgia : an international journal of headache.

[61]  A. Straube,et al.  Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study , 2005, Pain.

[62]  A. Sunshine,et al.  Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine , 2005, Headache.

[63]  S. Silberstein,et al.  Acetaminophen, Aspirin, and Caffeine Versus Sumatriptan Succinate in the Early Treatment of Migraine: Results From the ASSET trial , 2005 .

[64]  R. Cady,et al.  Eletriptan in the Early Treatment of Acute Migraine: Influence of Pain Intensity and Time of Dosing , 2005, Cephalalgia : an international journal of headache.

[65]  H. Diener,et al.  Almotriptan in Migraine Patients Who Respond Poorly to Oral Sumatriptan: A Double‐Blind, Randomized Trial , 2005, Headache.

[66]  V. Demarin,et al.  Evidence Based Guidelines for Treatment of Primary Headaches : Report of The Croatian Neurovascular Society , 2005 .

[67]  R. Cady,et al.  Treating Early Versus Treating Mild: Timing of Migraine Prescription Medications Among Patients With Diagnosed Migraine , 2005, Headache.

[68]  C. Dahlöf,et al.  Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. , 2005, Clinical therapeutics.

[69]  J. Quiring,et al.  Aspirin Is Efficacious for the Treatment of Acute Migraine , 2005, Headache.

[70]  A. Calhoun,et al.  A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine , 2005, Neurology.

[71]  M. Lanteri-Minet,et al.  Recognition and Management of Migraine in Primary Care: Influence of Functional Impact Measured by the Headache Impact Test (HIT) , 2005, Cephalalgia : an international journal of headache.

[72]  B. Dora,et al.  A Randomized Prospective Placebo-Controlled Study of Intravenous Magnesium Sulphate vs. Metoclopramide in the Management of Acute Migraine Attacks in the Emergency Department , 2005, Cephalalgia : an international journal of headache.

[73]  E. Kiziltan,et al.  The Efficacy and Safety of Venlafaxine in the Prophylaxis of Migraine , 2005, Headache.

[74]  P. Bath,et al.  Association between hormone replacement therapy and subsequent stroke: a meta-analysis , 2005, BMJ : British Medical Journal.

[75]  P. Goadsby,et al.  Octreotide is not Effective in the Acute Treatment of Migraine , 2005, Cephalalgia : an international journal of headache.

[76]  J. Aschoff,et al.  Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine—Results From Phase 1 of the REALIZE Study , 2005, Headache.

[77]  R. Lipton,et al.  Petasites hybridus root (butterbur) is an effective preventive treatment for migraine , 2004, Neurology.

[78]  Ali Samii,et al.  Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies , 2004, BMJ : British Medical Journal.

[79]  G. Trapani,et al.  Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study , 2004, Neurological Sciences.

[80]  M. Atmaca,et al.  Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study , 2004, Clinical Neurology and Neurosurgery.

[81]  B. Rowe,et al.  Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials , 2004, BMJ : British Medical Journal.

[82]  H. Diener,et al.  Placebo-Controlled Comparison of Effervescent Acetylsalicylic Acid, Sumatriptan and Ibuprofen in the Treatment of Migraine Attacks , 2004, Cephalalgia : an international journal of headache.

[83]  J. Klapper,et al.  Benefits of Treating Highly Disabled Migraine Patients with Zolmitriptan while Pain is Mild , 2004, Cephalalgia : an international journal of headache.

[84]  S. Landy,et al.  Efficacy and tolerability of sumatriptan tablets administered during the mild‐pain phase of menstrually associated migraine , 2004, International journal of clinical practice.

[85]  J. Olesen,et al.  No effect of eletriptan administration during the aura phase of migraine , 2004, European journal of neurology.

[86]  M. Maizels,et al.  A Combination of Riboflavin, Magnesium, and Feverfew for Migraine Prophylaxis: A Randomized Trial , 2004, Headache.

[87]  H. Göbel,et al.  Efficacy of Phenazone in the Treatment of Acute Migraine Attacks: A Double-Blind, Placebo-Controlled, Randomized Study , 2004, Cephalalgia : an international journal of headache.

[88]  G. Sances,et al.  Characteristics of Menstrual and Nonmenstrual Attacks in Women with Menstrually Related Migraine Referred to Headache Centres , 2004, Cephalalgia : an international journal of headache.

[89]  S. Lydersen,et al.  A Randomized, Double Blind Study of the Prophylactic Effect of Hyperbaric Oxygen Therapy on Migraine , 2004, Cephalalgia : an international journal of headache.

[90]  R. Cady,et al.  Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe , 2004, Current medical research and opinion.

[91]  F. Skobieranda,et al.  Comparison of Rizatriptan 5 mg and 10 mg Tablets and Sumatriptan 25 mg and 50 mg Tablets , 2004, Cephalalgia : an international journal of headache.

[92]  H. Diener,et al.  Efficacy of 1,000 mg Effervescent Acetylsalicylic Acid and Sumatriptan in Treating Associated Migraine Symptoms , 2004, European Neurology.

[93]  V. Papademetriou,et al.  Cardiovascular Safety of Triptans , 2004, Cephalalgia : an international journal of headache.

[94]  N. Mathew,et al.  Early Treatment of Migraine With Rizatriptan: A Placebo‐Controlled Study , 2004, Headache.

[95]  J. Dartigues,et al.  Impact of Headache on Quality of Life in a General Population Survey in France (GRIM2000 Study) , 2004, Headache.

[96]  C. Lines,et al.  Montelukast for Migraine Prophylaxis: A Randomized, Double‐Blind, Placebo‐Controlled Study , 2004, Headache.

[97]  C. Lines,et al.  Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine , 2004, Neurology.

[98]  S. Silberstein,et al.  Topiramate in Migraine Prevention: Results of a Large Controlled Trial , 2004 .

[99]  A. Dowson,et al.  Almotriptan Improves Response Rates When Treatment Is Within 1 Hour of Migraine Onset , 2004, Headache.

[100]  M. Atkinson,et al.  Health and Quality of Life Outcomes , 2004 .

[101]  J. Saper,et al.  Topiramate for migraine prevention: a randomized controlled trial. , 2004, JAMA.

[102]  SW Powers,et al.  Quality of Life in Paediatric Migraine: Characterization of Age-Related Effects Using PedsQL 4.0 , 2004, Cephalalgia : an international journal of headache.

[103]  E. Loder,et al.  Efficacy and Tolerability of Oral Zolmitriptan in Menstrually Associated Migraine: A Randomized, Prospective, Parallel‐Group, Double‐blind, Placebo‐Controlled Study , 2004, Headache.

[104]  D. Ashcroft,et al.  Naratriptan for the treatment of acute migraine: meta‐analysis of randomised controlled trials , 2004, Pharmacoepidemiology and drug safety.

[105]  J. Schoenen,et al.  Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: results of a multicenter, randomized, placebo-controlled study. , 2004, Clinical therapeutics.

[106]  M. Kosinski,et al.  Using item response theory to calibrate the Headache Impact Test (HIT™) to the metric of traditional headache scales , 2003, Quality of Life Research.

[107]  H. Diener,et al.  Comparative Efficacy of Eletriptan and Zolmitriptan in the Acute Treatment of Migraine , 2003, Cephalalgia : an international journal of headache.

[108]  E. MacGregor,et al.  Comparative Efficacy of Eletriptan vs. Naratriptan in the Acute Treatment of Migraine , 2003, Cephalalgia : an international journal of headache.

[109]  D. Patrick,et al.  Measuring satisfaction with migraine treatment: expectations, importance, outcomes, and global ratings. , 2003, Clinical therapeutics.

[110]  N. Mathew.  Early Intervention With Almotriptan Improves Sustained Pain‐free Response in Acute Migraine , 2003, Headache.

[111]  S. Powers,et al.  Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses. , 2003, Pediatrics.

[112]  J. Olesen,et al.  Eletriptan for the Treatment of Migraine in Patients with Previous Poor Response or Tolerance to Oral Sumatriptan , 2003, Cephalalgia : an international journal of headache.

[113]  M. Vray,et al.  Assessing the Severity of Migraine: Development of the MIGSEV Scale , 2003, Headache.

[114]  R. Lipton,et al.  Assessment of Migraine Disability Using the Migraine Disability Assessment (MIDAS) Questionnaire: A Comparison of Chronic Migraine With Episodic Migraine , 2003, Headache.

[115]  J. Schoenen,et al.  Comparative Efficacy of Eletriptan 40 mg Versus Sumatriptan 100 mg , 2003, Headache.

[116]  W. Stewart,et al.  Migraine Disability Assessment (MIDAS) Score: Relation to Headache Frequency, Pain Intensity, and Headache Symptoms , 2003, Headache.

[117]  J. Dartigues,et al.  Prevalence and description of chronic daily headache in the general population in France , 2003, Pain.

[118]  F. Sheftell,et al.  Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine: A Multicenter, Double‐Blind, Placebo‐Controlled Study Conducted in the United States , 2003, Headache.

[119]  J. Rothrock,et al.  Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial , 2003 .

[120]  R. Lipton,et al.  Need for Care and Perceptions of MIDAS among Headache Sufferers Study , 2002, CNS Drugs.

[121]  G. Nappi,et al.  Hormone Supplementation Differently Affects Migraine in Postmenopausal Women , 2002, Headache.

[122]  J. Dartigues,et al.  Prevalence and clinical characteristics of migraine in France , 2002, Neurology.

[123]  C. Bordini,et al.  Intravenous Magnesium Sulphate in the Acute Treatment of Migraine Without Aura and Migraine with Aura. A Randomized, Double-Blind, Placebo-Controlled Study , 2002, Cephalalgia : an international journal of headache.

[124]  A. Dowson,et al.  Mouth‐Dispersible Aspirin in the Treatment of Migraine: A Placebo‐Controlled Study , 2002, Headache.

[125]  G. Géraud,et al.  Zolmitriptan versus a Combination of Acetylsalicylic Acid and Metoclopramide in the Acute Oral Treatment of Migraine: A Double-Blind, Randomised, Three-Attack Study , 2002, European Neurology.

[126]  J. Pascual,et al.  Within‐Patient Early Versus Delayed Treatment of Migraine Attacks With Almotriptan: The Sooner the Better , 2002, Headache.

[127]  S. Powers,et al.  PedMIDAS: Development of a questionnaire to assess disability of migraines in children , 2001, Neurology.

[128]  F. Facchinetti,et al.  Course of primary headaches during hormone replacement therapy. , 2001, Maturitas.

[129]  R. Lipton,et al.  Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study , 2001, Headache.

[130]  J. Dartigues,et al.  Economic Impact of Migraine and Other Episodic Headaches in France , 2012, PharmacoEconomics.

[131]  S. Silberstein,et al.  Oral Zolmitriptan in the Short-Term Prevention of Menstrual Migraine , 2008, CNS drugs.

[132]  [Treatment guidelines for preventive treatment of migraine]. , 2008, Acta neurologica Taiwanica.

[133]  R. Cady,et al.  Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine. , 2007, Mayo Clinic proceedings.

[134]  D. Dodick,et al.  Speed of Onset, Efficacy and Tolerability of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine , 2005, CNS drugs.

[135]  H. Diener,et al.  Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control. , 2004, Journal of neurology.

[136]  A. Pradalier,et al.  The PROMISE Study: PROphylaxis of Migraine with SEglor® (Dihydroergotamine Mesilate) in French Primary Care , 2004, CNS drugs.

[137]  A. Dowson,et al.  Speed of Onset and Efficacy of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine , 2003, CNS drugs.

[138]  B. Laurent,et al.  [Validation of the combined SF36/MSQOL test of evaluation of quality of life in migraine patients in France]. , 2002, Revue neurologique.